Can a new potential treatment combining an SGLT-2 and a GLP-1 RA mitigate cardiometabolic risk?
Read More »The Discordance Between the Glucose Management Indicator and HbA1C
Evaluating the discordance between laboratory and continuous glucose monitoring estimated HbA1c.
Read More »Ertugliflozin Proved Effective in Patients with Type 2 Diabetes and ASCVD
A VERTIS CV sub study showed significant improvements in glycemic control after adding ertugliflozin to insulin-based regimens.
Read More »Could There be a Way to Prevent Type 1 Diabetes?
According to two new studies, researchers have seen tremendous progress in delaying the onset of type one diabetes and slowing down the disease's progression.
Read More »ADA 81st Symposium: Optimizing Prevention Interventions for Type 2 Diabetes
American Diabetes Association mini-symposium presented by Mike Sampson, MD.
Read More »ADA 81st Symposium: Evidence-Based Guidelines For Diabetes and Chronic Kidney Disease
Diabetes is the leading cause of chronic kidney disease due to microvascular damage to the renal blood vessels.
Read More »Diabetes and Children’s Brain Development
A recent longitudinal study examines diabetes type 1 and brain cognitive differences in children.
Read More »ADA 81st Symposium: Treatment for Prediabetes and Diabetes Can Be Found at a Grocery Store, Part 1
A prescription for vegetables can significantly lower weight, blood pressure, and A1C.
Read More »ADA 81st Symposium: Treatment for Prediabetes and Diabetes Can Be Found at a Grocery Store, Part 2
Better food choices can lower the incidence of diabetes and kidney disease, and reduce the need for medications.
Read More »ADA 81st Symposium: The Effect of Nasal Glucagon in Insulin-Induced Hypoglycemia
The preparation of nasal glucagon is immediate and intended for use in an emergency hypoglycemic event, but how well can it reverse these events?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.